Home  /  
Articles  /  

Why I Use… Septocaine

Author
By: Dental Product Shopper
3/20/2024

Articaine-based local anesthetic offers effective pain control, as well as predictable onset and duration of anesthesia

 

wiusepto00.png

MEL HAWKINS, DDS, BSCD AN, FADSA, DADBA

Dr. Hawkins graduated from the University of Toronto with his DDS degree and returned for his formal training in dental anesthesiology at the same university. He is the founding director of the intravenous sedation continuing education program at the University of Alberta, and was the founding director of the intravenous sedation program at the University of Toronto. He has over 30 years of private practice experience in Toronto, Canada. In addition to lecturing throughout the U.S. and Europe for over 20 years, Dr. Hawkins is board-certified as a Diplomate of the American Dental Board of Anesthesiologists and is a Fellow of the American Dental Society of Anesthesiology. He also holds fellowships with the International College of Dentists and with the Pierre Fouchard International Academy. He has served on the continuing education committee for the American Dental Society of Anesthesiology.

 

 For Dr. Mel Hawkins, a Diplomate of the American Dental Board of Anesthesiologists, there's a reason why Septodont's Septocaine is the No. 1-branded dental local anesthetic in the United States. Here, he explains why he recommends this articaine-based anesthetic for straightforward and complex dental procedures both for patients-—and for himself.

 

wiusepto01.png

Every dentist knows that achieving patient satisfaction ultimately comes down to comfort during dental procedures. So, whenever I’m asked why I use Septocaine for my patients, I say that it has a scientifically proven success rate and its onset time and duration are predictable. I’ve had a lot of dentistry done in my own mouth over the years, and whenever I undergo any treatment, I insist that my partner use this product for both blocks and infiltration.

 

There's so much evidence about this local anesthetic. Unlike lidocaine-based local anesthetics that are commonly used in dentistry, Septocaine is articaine-based. Articaine has a short half-life of 27 minutes, compared to the 90-minute half-life of almost all other commercially available amide local anesthetics.

 

Predictable, Safe, and Effective

 

Septocaine has a predictable duration of anesthesia for up to 60 minutes for infiltration injections and up to 120 minutes for nerve blocks. This molecule not only has a reliable track record for infiltration success in the maxilla, but it also has proved valuable for performance in several mandibular areas. Ohio State University studies have shown that the lower first permanent molars are reliably infiltrated with Septocaine, whereas when lidocaine is attempted for infiltration for those same 2 first molars, it is statistically not as reliable.

 

Along with Dr. Paul Moore from the University of Pittsburgh, I did a research study dating back to 1976 and could not find a single death that was solely attributable to articaine overdose, even in higher-risk geriatric and pediatric populations. We concluded and published in Dental Clinics of North America that its safety may be due to its short half-life and the body's inability to build up toxic metabolites, thereby reducing the risk of overdose.

 

We should always consider contraindications, starting with allergies, specifically those related to the sodium metabisulfite antioxidant included in a cartridge for stabilizing epinephrine. It's important to note that patients do not generally exhibit an allergic response to epinephrine, since epinephrine (or adrenalin) is naturally present in our bodies. Although possible, allergy to sodium metabisulfite is relatively rare. Given that articaine functions as a potent vasodilator, its reliance on epinephrine is essential, since without it, the effect of articaine would be relatively short.

 

In conversations about Septocaine with fellow clinicians, I underscore both its predictable efficacy and its proven absence of neurotoxicity. It appears that the myth of articaine being causative of paresthesia in inferior alveolar blocks or lingual blocks is no longer valid

 

Reference: Albalawi F, Hersh EV. Effects of lidocaine and articaine on neuronal survival and recovery. Anesth Prog. 2018;65:82–88.

Shop Now